Here are three things to know about the deal.
1. Teleflex develops devices for surgery, cardiac, respiratory and emergency care. Vascular Solutions offers devices for diagnostic and interventional vascular procedures.
2. Teleflex’s offer of $56 per share represents a premium of 1.6 percent on the stock’s closing value as of Thursday, according to a Reuters report.
3. The deal is expected to close in the first half of 2017.
More articles on supply chain:
How Amazon trains new warehouse workers in just 2 days
Ariad Pharma earns full FDA approval for cancer drug Iclusig
Trump picks Elaine Chao for transportation secretary: 7 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
